Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients

Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, a significant proportion of gastric cancer (GC) patients do not respond to this therapy. Consequently, there is an urgent need to elucidate the mechanisms underlying resistance to ICIs and identify robust...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiangang Sun, Xiaojing Li, Qian Wang, Peng Chen, Longfei Zhao, Yongshun Gao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-05-01
coleção:	Frontiers in Pharmacology
Assuntos:	gastric cancer immune checkpoint inhibitor proteomics machine learning biomarkers
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1349459/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!